@article{fabcf95a165a46b497e789326af41b0c,
title = "Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial: Insights From the Department of Veterans Affairs",
keywords = "cholesterol, clinical trial",
author = "Virani, {Salim S.} and Akeroyd, {Julia M.} and Vijay Nambi and Michos, {Erin D.} and Morris, {Pamela B.} and Khurram Nasir and Smith, {Sidney C.} and Stone, {Neil J.} and Petersen, {Laura A.} and Ballantyne, {Christie M.}",
year = "2019",
month = jan,
day = "15",
doi = "10.1161/CIRCULATIONAHA.118.034993",
language = "English (US)",
volume = "139",
pages = "410--412",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "3",
}